Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) EBT (2016 - 2025)

Historic EBT for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$11.9 million.

  • Orthopediatrics' EBT fell 3021.78% to -$11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.8 million, marking a year-over-year decrease of 4136.26%. This contributed to the annual value of -$41.9 million for FY2024, which is 9673.89% down from last year.
  • Per Orthopediatrics' latest filing, its EBT stood at -$11.9 million for Q3 2025, which was down 3021.78% from -$7.1 million recorded in Q2 2025.
  • Orthopediatrics' EBT's 5-year high stood at $14.4 million during Q3 2022, with a 5-year trough of -$16.4 million in Q4 2024.
  • Moreover, its 5-year median value for EBT was -$7.1 million (2025), whereas its average is -$6.0 million.
  • Examining YoY changes over the last 5 years, Orthopediatrics' EBT showed a top increase of 67838.49% in 2022 and a maximum decrease of 465662.65% in 2022.
  • Over the past 5 years, Orthopediatrics' EBT (Quarter) stood at -$166000.0 in 2021, then crashed by 4656.63% to -$7.9 million in 2022, then grew by 12.58% to -$6.9 million in 2023, then plummeted by 137.71% to -$16.4 million in 2024, then rose by 27.49% to -$11.9 million in 2025.
  • Its EBT stands at -$11.9 million for Q3 2025, versus -$7.1 million for Q2 2025 and -$10.5 million for Q1 2025.